These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 30834862)

  • 1. Validation and effect on diabetes control of glycated haemoglobin (HbA1c) point-of-care testing.
    Pillay S; Aldous CM; Singh D; Pillay D
    S Afr Med J; 2019 Jan; 109(2):112-115. PubMed ID: 30834862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of POCT in the diabetic clinic in a large hospital.
    Tanyanyiwa D; Dandara C; Bhana SA; Pauly B; Marule F; Ramokoka M; Bwititi P; Nwose U; Nkosi B
    Afr Health Sci; 2015 Sep; 15(3):902-7. PubMed ID: 26957980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point-of-care testing for haemoglobin A1c in remote Australian Indigenous communities improves timeliness of diabetes care.
    Spaeth BA; Shephard MD; Schatz S
    Rural Remote Health; 2014; 14(4):2849. PubMed ID: 25359698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a point-of-care analyser for the determination of HbA1c with HPLC method.
    Grant DA; Dunseath GJ; Churm R; Luzio SD
    Pract Lab Med; 2017 Aug; 8():26-29. PubMed ID: 28856223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Patient Satisfaction with On-Site Point-of-Care Hemoglobin A1c Testing: An Observational Study.
    Al Hayek AA; Al-Saeed AH; Alzahrani WM; Al Dawish MA
    Diabetes Ther; 2021 Sep; 12(9):2531-2544. PubMed ID: 34363602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of Point-of-Care Testing Compared with the Standard Laboratory Diagnostic Test in the Measurement of HbA1c in Indonesian Diabetic and Nondiabetic Subjects.
    Berbudi A; Rahmadika N; Tjahjadi AI; Ruslami R
    J Diabetes Res; 2020; 2020():2037565. PubMed ID: 32733964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Point-Of-Care Testing in General Practice for Type 2 Diabetes Patients on Ambulatory Visits and Hospitalizations.
    Kristensen T; Rose-Olsen K; Volmar Skovsgaard C
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32858923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lot variation and inter-device differences contribute to poor analytical performance of the DCA Vantage™ HbA
    Abildgaard A; Knudsen CS; Bjerg LN; Lund S; Støy J
    Clin Chem Lab Med; 2022 Jan; 60(1):127-134. PubMed ID: 34480844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycated haemoglobin (HbA1c) use and glycaemic control in patients living with diabetes mellitus attending public healthcare facilities in KwaZulu-Natal Province, South Africa.
    Pillay S; Pillay D; Pillay R
    S Afr Med J; 2021 Nov; 111(11):1060-1064. PubMed ID: 34949269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Point-of-Care Hemoglobin A1c Testing on Population Health-Based Onsite Testing Adherence: A Primary-Care Quality Improvement Study.
    Crocker JB; Lynch SH; Guarino AJ; Lewandrowski K
    J Diabetes Sci Technol; 2021 May; 15(3):561-567. PubMed ID: 33233954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a training program for device operators in the Australian Government's Point of Care Testing in General Practice Trial: issues and implications for rural and remote practices.
    Shephard MD; Mazzachi BC; Watkinson L; Shephard AK; Laurence C; Gialamas A; Bubner T
    Rural Remote Health; 2009; 9(3):1189. PubMed ID: 19689171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of HbA1c Point of Care Testing in 3 German Medical Practices: Impact on Workflow and Physician, Staff, and Patient Satisfaction.
    Patzer KH; Ardjomand P; Göhring K; Klempt G; Patzelt A; Redzich M; Zebrowski M; Emmerich S; Schnell O
    J Diabetes Sci Technol; 2018 May; 12(3):687-694. PubMed ID: 29532694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concordance of three point of care testing devices with clinical chemistry laboratory standard assays and patient-reported outcomes of blood sampling methods.
    Yonel Z; Kuningas K; Sharma P; Dutton M; Jalal Z; Cockwell P; Webber J; Narendran P; Dietrich T; Chapple ILC
    BMC Med Inform Decis Mak; 2022 Sep; 22(1):248. PubMed ID: 36138408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of exogenous human insulin dose adjustment on body mass index in adult patients with type 1 diabetes mellitus at Kalafong Hospital, Pretoria, South Africa, 2009 - 2014.
    Sehloho TSA; Van Zyl DG
    S Afr Med J; 2017 May; 107(6):528-534. PubMed ID: 28604327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early experiences with quality-assured HbA1c and professional glucose point-of-care testing in general practice: a cross-sectional observational study among patients, nurses and doctors.
    Smits M; Hopstaken R; Terhaag L; de Kort G; Giesen P
    BMC Nurs; 2022 Jul; 21(1):183. PubMed ID: 35804341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparability of Point-of-Care versus Central Laboratory Hemoglobin Determination in Emergency Patients at a Supra-Maximal Care Hospital.
    Dolscheid-Pommerich RC; Dolscheid S; Grigutsch D; Stoffel-Wagner B; Graeff I
    PLoS One; 2016; 11(11):e0166521. PubMed ID: 27880783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major depressive disorder in patients with diabetes mellitus in Pietermaritzburg, South Africa.
    Jansen van Vuuren JM; Pillay S
    S Afr Med J; 2018 Dec; 109(1):58-61. PubMed ID: 30606306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of demographic and behavioural factors with glycaemic control in young adults with type 1 diabetes mellitus.
    Osan JK; Punch JD; Watson M; Chan YX; Barrie P; Fegan PG; Yeap BB
    Intern Med J; 2016 Mar; 46(3):332-8. PubMed ID: 26748888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating point-of-care testing for glycosylated haemoglobin in public sector primary care facilities in the Western Cape, South Africa.
    Mash R; Ugoagwu A; Vos C; Rensburg M; Erasmus R
    S Afr Med J; 2016 Dec; 106(12):1236-1240. PubMed ID: 27917770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value proposition for point-of-care testing in healthcare: HbA1c for monitoring in diabetes management as an exemplar.
    Price CP; St John A
    Scand J Clin Lab Invest; 2019 Sep; 79(5):298-304. PubMed ID: 31082284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.